Recently, we found that CstF-50 interacts with BARD1 Results in vitro and, together with BRCA1, in vivo, and that this interaction represses the polyadenylation machinery in DNA Damage Inhibits Polyadenylation In Vitro BARD1, together with BRCA1, interacts with the mRNA in vitro functional assays (Kleiman and Manley, 1999). We suggested that BARD1-mediated inhibition of polypolyadenylation factor CstF-50 and represses the activ-ity of the polyadenylation machinery in vitro (Kleiman and Manley, 1999 Figure 1A ). Inhibition was observed from 2-8 hr of HU treatment, but cleavage was restored after 10 hr, reaching the levels of untreated cells. As discussed below, the transient nature of the inhibition is consistent with previously characterized responses to DNA damage and, in any event, indicates that the effect was not due to an irre- were observed with another pre-mRNA substrate, adenovirus L3 ( Figure 1C ), indicating that the inhibition was (CstF-64 and CPSF-160) in response to UV (Figures 2A likely a general effect on 3Ј end formation, and not reand 2C, respectively) or HU (data not shown), indicating lated to the unusual PAP independence of SV40 late that cleavage inhibition was not due to decreased conpre-mRNA 3Ј cleavage (e.g., Hirose and Manley, 1998).
centrations of these two important cleavage factors. Cleavage was not inhibited in reaction mixtures in which Since BARD1 forms a complex with CstF and inhibits NE from untreated and 5 hr UV-treated cells were mixed polyadenylation in vitro (Kleiman and Manley, 1999), (Figure 1D ), suggesting that the treated extracts did not changes in its expression level could explain the decontain excess amounts of a diffusible inhibitor. Both crease in 3Ј end formation observed under DNA damage HU and UV-treated NEs were also tested for their ability conditions. However, Western blotting revealed that neito perform pre-mRNA splicing. Although there was some ther BARD1 ( Figure 2B ) nor BRCA1 ( Figure 2D ) levels variability, no significant decreases in splicing efficiency changed significantly in response to UV treatment. This were detected at the times 3Ј cleavage was inhibited, result is consistent with the fact that the steady-state indicating that extracts were not generally inactivated levels of BARD1 and BRCA1 remain relatively constant ( Figure 1E) We were intrigued by the fact that the only known 4D), indicating that CstF may be limiting for processing under these conditions. However, addition of CstF to tumor-associated germline mutation in BARD1 (Gln564His) was found to lie within the CstF-50 interacthe inhibited NE strongly increased cleavage, allowing efficiencies similar to that observed in the nontreated NE tion domain (Kleiman and Manley, 1999) . In order to investigate the possible effects of this mutation on at the highest CstF concentration. These results provide strong evidence that CstF is indeed the target of BARD1-BARD1 function in polyadenylation, we constructed a GST-BARD1 fusion protein containing the Gln564His mediated inhibition in extracts prepared from UVtreated cells. mutation ( Figure 5A ). The proteins were first used in binding assays with in vitro translated CstF-50, as described previously (Kleiman and Manley, 1999). As ex-A Tumor-Associated Mutation in BARD1 Abolishes BARD1-Mediated Inhibition pected, a significant amount of the input CstF-50 bound to GST-BARD1 but not to GST alone ( Figure 5C ). The of mRNA Polyadenylation The above data provide considerable support for the Gln564His mutation significantly and reproducibly reduced binding, indicating that this residue is important existence of an inhibitory effect of DNA damage on premRNA polyadenylation, and for this response being mefor optimal interaction. This is similar to the behavior of a GST-BARD1 derivative with a COOH-terminal truncation diated at least in part by BARD1. To obtain genetic support for the significance of this interaction, as well removing most of the BRCT domain (GST-BARD1 (13-638); Figure 5A ), which also displayed reduced binding as to test the idea that it might be related to the possible (see also Kleiman and Manley, 1999) . To examine the due to general misfolding of the protein or to some other nonspecific effect. effect of the Gln564His mutation on the BARD1/CstF-50 interaction in more detail, we determined the sensitivity We next wished to determine whether the Gln564His mutation influences the inhibitory effect of BARD1 on of the interaction to elevated salt concentrations ( Figure  5D ). Increasing the NaCl concentration in the washing 3Ј cleavage in NE. We first analyzed the ability of the wild-type and Gln564His mutant GST-BARD1 proteins buffer resulted in a significant decrease in the amount of CstF-50 bound to GST-BARD1 Gln564His, such that to interact with intact CstF and, as a control, BRCA1 in standard HeLa NEs used for processing reactions. binding was nearly undetectable at the highest concentration. Elevated salt also reduced binding to wild-type Bound proteins were detected by Western blotting using anti-CstF-64 and BRCA1 antibodies ( Figure 6A) . A signif-GST-BARD1, but the decrease was relatively minor. Thus, under more stringent conditions, the tumor-assoicant amount of CstF-64 bound to GST-BARD1 but not to GST alone. Importantly, the Gln564His mutation sigciated Gln564His mutation strongly inhibits the BARD1/ CstF-50 interaction.
nificantly reduced binding, indicating that the mutation affects interaction with intact CstF as well as with CstF-BARD1 can homodimerize as well as form heterodimers with BRCA1 via its NH 2 -terminal domain, which 50 (see above). As expected, both GST-BARD1 derivates showed similar binding to endogenous BRCA1. includes a RING finger motif (Wu et al., 1996; Ayi et al., 1998; Meza et al., 1999). We next examined whether the We next monitored 3Ј cleavage of the SV40 pre-mRNA in standard NE incubated with no addition or with inGln564His mutation affected either of these interactions, using the three GST-BARD1 derivates employed above creasing amounts of each of the three GST-BARD1 derivates analyzed in Figure 6B . As observed before (Kleiand in vitro translated BRCA1 and BARD1 in binding assays ( Figures 5E and 5F, respectively) . A significant man and Manley, 1999), addition of increasing amounts of purified GST-BARD1 to reaction mixtures effectively amount of the input BARD1 and BRCA1 bound to GST-BARD1 but not to GST. However, both of the GSTinhibited cleavage, almost completely at the highest concentrations ( Figure 6B, lanes 8-10) . Strikingly, the BARD1 mutants, and most importantly the Gln564His derivative, displayed the same level of binding as wild GST-BARD1 Gln564His protein was without detectable effect on cleavage at all concentrations tested (lanes type. These results indicate that the observed decrease in binding of the Gln564His protein to CstF-50 was not 2-4). In contrast, and also as shown before (Kleiman Another interesting link between DNA repair and polyspecific factors in the complexes, but due to characteristics of the target transcripts. adenylation is provided by a study documenting enhanced synthesis of the protein elastin in sun-damaged Based on properties of BRCA1, BARD1, and CstF, we propose that BARD1, as part of a complex recruited to skin (Schwartz et al., 1998 
